311 related articles for article (PubMed ID: 30892297)
1. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
4. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of smart stimuli-responsive mesoporous organosilica nano-vehicles for targeted pesticide delivery.
Liang Y; Gao Y; Wang W; Dong H; Tang R; Yang J; Niu J; Zhou Z; Jiang N; Cao Y
J Hazard Mater; 2020 May; 389():122075. PubMed ID: 31972522
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
10. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
11. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
[TBL] [Abstract][Full Text] [Related]
12. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
[TBL] [Abstract][Full Text] [Related]
14. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
Li X; Zhang X; Zhao Y; Sun L
J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
[TBL] [Abstract][Full Text] [Related]
16. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
18. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
19. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]